Evidence map›Paper›PMID 39962846›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2024

[Analysis of Clinical Epidemiological Characteristics of 15,967 Lung Cancer Surgery Patients in Yunnan Cancer Hospital from 2013 to 2022].

Ruke Tang, Yujie Lei, Lianhua Ye, Guangqiang Zhao, Xudong Xiang, Gaofeng Li, Guangjian Li, Xi Wang, Ying Chen, Kaiyun Yang and 8 more

Abstract readEnglish Abstract
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ruke TangDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Yujie LeiDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Lianhua YeDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Guangqiang ZhaoDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Xudong XiangDepartment of Thoracic Surgery II, Yunnan Cancer Hospital, Kunming 650118, China.
Gaofeng LiDepartment of Thoracic Surgery II, Yunnan Cancer Hospital, Kunming 650118, China.
Guangjian LiDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Xi WangDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Ying ChenDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Kaiyun YangDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Xiaobo ChenDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Jiapeng YangDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Min ZhaoDepartment of Medical Administration, Yunnan Cancer Hospital, Kunming 650118, China.
Bingquan XiangDepartment of Intensive Care Unit, Yunnan Cancer Hospital, Kunming 650118, China.
Qiubo HuangDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Guangcan LuoDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Hongwei ZhangDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.
Yunchao HuangDepartment of Thoracic Surgery I, Yunnan Cancer Hospital, Kunming 650118, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer is a disease with a high incidence rate in Yunnan province, yet there is a paucity of large-scale studies on its clinical epidemiology. This research aims to investigate the epidemiological characteristics of patients who underwent lung cancer surgery at Yunnan Cancer Hospital over the past decade, thereby providing a theoretical basis for the prevention and treatment of lung cancer.

methodsClinical data were collected from 15,967 patients who underwent lung cancer surgery at Yunnan Cancer Hospital between 2013 and 2022. A statistical analysis was conducted on the patients' general data, surgical information, pathological types of lung cancer, and other clinical epidemiological characteristics.

resultsAmong the 15,967 cases of lung cancer, 46.3% were male and 53.7% were female, with the male-to-female ratio ranging from 0.68 to 1.61:1. The median age was 56 years (interquartile range: 49-63), and 37.0% of the patients were in the age group of 50-59 years. Since 2017, there has been an annual increase in the proportion of patients under the age of 60 years. The smoking status of the patients showed that 28.1% were smokers and 71.9% were non-smokers. Qujing city accounted for 41.4% and Kunming city for 23.2% of the cases in Yunnan province, with 29.6% of patients originating from Xuanwei and Fuyuan areas of Qujing city. The distribution of affected lung lobes was as follows: right upper lobe 28.2%, right middle lobe 6.3%, right lower lobe 20.1%, left upper lobe 22.7%, and left lower lobe 16.4%. The use of thoracoscopic surgery increased from 30.8% to 96.3%, with single-port thoracoscopic surgery comprising 61.3%. Lobectomy was performed in 64.2% of cases, wedge resection in 17.2%, and segmentectomy in 12.2%. The proportion of lobectomy decreased from 83.1% to 46.1%. The proportion of patients in stages 0-I increased from 43.5% to 82.8%, while stages II-IV decreased from 56.5% to 17.2%. Adenocarcinoma increased from 75.6% to 88.3%, and squamous cell carcinoma decreased from 21.5% to 8.6%. Among adenocarcinoma patients, 60.9% were female. Among sguamous cell carcinoma patients, 90.6% were male. The peak age for adenocarcinoma was 50-59 years, and for squamous cell carcinoma, it was 60-69 years. The smoking rate was higher among squamous cell carcinoma patients (65.9%) compared to adenocarcinoma patients (22.3%). Adenocarcinoma patients had a higher proportion in stages 0-I (76.3%), while squamous cell carcinoma patients were more prevalent in stages II-III (64.1%).

conclusionsThe findings indicate an increasing proportion of female patients with adenocarcinoma, a younger age of onset, a higher proportion of non-smoking lung cancer patients, and an increased proportion of stages 0-I lung cancer. These trends may reflect the epidemiological characteristics of patients undergoing lung cancer surgery in Yunnan and surrounding areas over the past decade.

Indexed as

Lung NeoplasmsAdultAgedAged, 80 and overChinaFemaleHumansMaleMiddle AgedEpidemiologyLung neoplasmsPathological typeSurgeryYunnan

Identifiers

PMID39962846
PMCPMC11839495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.